Global Oral Solid Dosage Manufacturing Market Growth (Status and Outlook) 2025-2031

The global Oral Solid Dosage Manufacturing market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Oral solid dosage manufacturing refers to the process of producing pharmaceutical products in solid form that are intended to be taken orally, such as tablets, capsules, and powders. This manufacturing process involves several steps, including formulation development, blending, granulation, compression, coating, and packaging.

Formulation development is the initial stage where the active pharmaceutical ingredient (API) and other excipients are selected and combined to create a stable and effective dosage form. Blending involves mixing the API and excipients to ensure uniform distribution of the drug throughout the dosage form. Granulation is the process of forming granules from the blended mixture to improve flowability and compressibility.

Compression is the step where the granules are compressed into tablets or filled into capsules using specialized equipment. Coating may be applied to tablets to improve appearance, taste, and stability, as well as to control the release of the drug. Finally, the finished dosage forms are packaged in appropriate containers, such as blister packs or bottles, and labeled for distribution.

Oral solid dosage manufacturing requires strict adherence to Good Manufacturing Practices (GMP) to ensure the quality, safety, and efficacy of the pharmaceutical products. This includes maintaining a controlled manufacturing environment, conducting regular quality control testing, and following standard operating procedures to prevent contamination and ensure consistency in the manufacturing process.

United States market for Oral Solid Dosage Manufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Oral Solid Dosage Manufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Oral Solid Dosage Manufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Oral Solid Dosage Manufacturing players cover CRB, LGM Pharma, Pfizer, Piramal Group, Avara Pharmaceutical Services, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Oral Solid Dosage Manufacturing Industry Forecast” looks at past sales and reviews total world Oral Solid Dosage Manufacturing sales in 2024, providing a comprehensive analysis by region and market sector of projected Oral Solid Dosage Manufacturing sales for 2025 through 2031. With Oral Solid Dosage Manufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Solid Dosage Manufacturing industry.

This Insight Report provides a comprehensive analysis of the global Oral Solid Dosage Manufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oral Solid Dosage Manufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Solid Dosage Manufacturing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Solid Dosage Manufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Solid Dosage Manufacturing.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Solid Dosage Manufacturing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Wet Granulation
Dry Granulation
Direct Compression
Particle Coating
Other

Segmentation by Application:
Drug Formulation Development
Formulation Production

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CRB
LGM Pharma
Pfizer
Piramal Group
Avara Pharmaceutical Services
Alcami
Thermo Fisher Scientific
Recipharm
Metrics Contract Services
BOC Sciences
Societal CDMO
DFE Pharma
NNE
Pharma Access

Please note: The report will take approximately 2 business days to prepare and deliver.